SARS-CoV-2

SARS-CoV-2

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • Government is considering providing a vaccine to protect babies from RSV

    A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector but not yet in public clinics. The country’s advisory group on immunisations has recommended making it available to all pregnant women. Catherine Tomlinson reports that this proposal is now under review by the National Department of…

    ·

  • Don’t panic about new SARS-CoV-2 variant, experts say

    COVID-19 has largely dropped out of the headlines, but the virus that causes it is still circulating. Biénne Huisman asks what we should know about a new variant of SARS-CoV-2, the state of the COVID-19 pandemic in 2025, and the lack of access to updated vaccines in South Africa.

    ·

  • Growing the beta variant – young scientist remembers the day they danced in the lab

    During South Africa’s COVID-19 hard lockdown, rising star scientist Dr Sandile Cele spent his Christmas holidays in a laboratory. Soon the 35-year-old became the first to successfully grow the beta variant of SARS-CoV-2 in the lab. Biénne Huisman spoke to Cele about how he did this, the string of accolades he received since, and his…

    ·

  • What it means to build genomics capacity in Africa

    During the COVID-19 pandemic, we saw the remarkable power of genomics in helping us keep track of new viral variants. Several scientists argue that Africa should continue to invest in genomics to support disease control and public health. Sue Segar asks what this means in practice and why it is considered so critically important.

    ·

  • What next as COVID-19 shots expire and become harder to get?

    Millions of doses of the Pfizer-BioNtech COVID-19 vaccine procured by the South African government have expired and the shot is largely unavailable to people in the country. Meanwhile, earlier this month, the World Health Organization declared an end to the COVID-19 ‘Public Health Emergency of International Concern’. Adele Baleta asks what all this means for…

    ·

  • What’s the deal with viral variants when it comes to HIV?

    A study published last year on an HIV variant that has been circulating in the Netherlands for the last 20 years reminded the public of the existence of viral variants beyond SARS-CoV-2. Elri Voigt unpacks what we know about the HI-virus, its variants, and the study’s findings.

    ·

  • HIV vaccine research set to change focus in wake of Mosaico disappointment

    Top South African HIV clinicians are setting their sights on different approaches to finding an HIV vaccine after the “disappointing” news that the Mosaico trial was stopped early because the vaccine did not show any efficacy. The search for an HIV jab now seems set to pivot from vaccines that induce T-cell immunity to ones…

    ·

  • COVID-19: The role of next-generation vaccines in immunity

    Indications are that the virus that causes COVID-19 is going to continue evolving and escaping the protection against infection people already have. Researchers are working on next-generation vaccines tailored to fight off specific versions of the virus, like the Omicron sub-lineages BA.4 and BA.5. But can these new vaccines be tested and produced fast enough…

    ·